Catalog No.
PHD50501
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human CDH3 (Gly371-Leu660).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
Placental cadherin,CDH3,Cadherin-3,P-cadherin,CDHP
Purification
Purified by antigen affinity column.
Accession
P22223
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer., PMID:39654063
Serum Level of Cadherin-P (CDH3) Is a Novel Predictor of Cardiovascular Events Related to Atherosclerosis in a 3-Year Follow-Up Study., PMID:39518432
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer., PMID:38309723
Dosimetry of a Novel 111Indium-Labeled Anti-P-Cadherin Monoclonal Antibody (FF-21101) in Non-Human Primates., PMID:37760501
The Role of Radiolabeled Monoclonal Antibodies in Cancer Imaging and ADC Treatment., PMID:36383907
Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implications., PMID:34656365
The expression and prognostic relevance of CDH3 in tongue squamous cell carcinoma., PMID:34580913
PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing Malignancies., PMID:33879555
Preclinical Characterization of the Radioimmunoconjugate 111In or 90Y-FF-21101 Against a P-Cadherin-Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate., PMID:32737245
Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis., PMID:31622668
Molecular pathology of the luminal class of urothelial tumors., PMID:31232464
Novel method for rapid identification of micropapillary or solid components in early-stage lung adenocarcinoma., PMID:30180981
Cell surface markers for the identification and study of human naive pluripotent stem cells., PMID:29227830
Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study., PMID:27745870
Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts., PMID:27160704
Limbal dermoid epithelium shares phenotypic characteristics common to both hair epidermal and limbal epithelial stem cells., PMID:23573994
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy., PMID:22223257
A mechanoresponsive cadherin-keratin complex directs polarized protrusive behavior and collective cell migration., PMID:22169071
PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity., PMID:20829331
The conserved miR-51 microRNA family is redundantly required for embryonic development and pharynx attachment in Caenorhabditis elegans., PMID:20421599
Molecular characterization of cultured adult human liver progenitor cells., PMID:19874131
Identification of human embryonic stem cell surface markers by combined membrane-polysome translation state array analysis and immunotranscriptional profiling., PMID:19650036
Inhibition of cell adhesion by xARVCF indicates a regulatory function at the plasma membrane., PMID:18729204
Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases., PMID:15833838
cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells., PMID:12730682
For research use only. Not for human or drug use.
